• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: ACTRIMS 2025

ACTRIMS Forum 2025 slide resource

March 28, 2025  

ACTRIMS Forum 2025 highlights – Update on ocrelizumab

March 24, 2025  

ACTRIMS Forum 2025: Update on biomarkers

March 17, 2025  

ACTRIMS Forum 2025 highlights – Focus on ofatumumab

March 10, 2025  

ACTRIMS Forum 2025 Highlights – Saturday, March 1, 2025

March 1, 2025  

ACTRIMS Forum 2025 Highlights – Friday, February 28, 2025

February 28, 2025  

Browse by Topic

  • MS (438)
  • CLINICAL CASES (20)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Reducing PIRA with high-efficacy DMTs in MS posted on May 11, 2026
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • CLINICAL CASES IN NEUROLOGY: A 55-y.o. with new MRI lesions posted on April 23, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions